AHA's scientific statement reveals exercise's vital role in obesity management, boosting cardiovascular health and supporting ...

As obesity rates continue to climb in the US, clinicians across specialties are confronting the reality that although ...

Thanks to GLP-1 medicines, losing weight is the easy part. The harder part for many may be convincing their brain that their ...

CMS rulemaking or Congress should remove the outdated coverage exclusion on obesity treatment for Medicare beneficiaries.

Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity ...

Novo Nordisk (CPSE:NOVO B) has launched the Wegovy pill in the UAE, the first country outside the U.S. to offer this oral obesity treatment. Regulators in the EU have issued positive opinions ...

Obesity treatment has entered a new era with innovative medications offering transformative results. Yet, a troubling reality persists: many who need these life-changing treatments most face the ...

The American Heart Association (AHA) has issued a statement emphasizing that exercise should be continued even if weight loss ...

'Obesity is a disease': Wegovy maker says UAE leads global shift with oral pill treatment ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, ...